Update on Dry Eye Disease Treatment: Evidence From Randomized Controlled Trials

Omur O. Ucakhan, Tuna Celik-Buyuktepe, Lin Yang, Brian Wogu, Penny A. Asbell

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Although the ultimate goal of dry eye disease (DED) management is to restore the ocular surface and tear film homeostasis and address any accompanying symptoms, addressing this is not an easy task. Despite the wide range of current treatment modalities targeting multiple aspects of DED, the available DED management literature is quite heterogeneous, rendering evaluation or comparison of treatment outcomes hard or almost impossible. There is still a shortage of well-designed, large-scale, non-sponsored, randomized, controlled trials (RCTs) evaluating long-term safety and efficacy of many targeted therapies individually or used in combination, in the treatment of identified subgroups of patients with DED. This review focuses on the treatment modalities in DED management and aims to reveal the current evidence available as deduced from the outcomes of RCTs.

Original languageEnglish
Pages (from-to)542-568
Number of pages27
JournalEye and Contact Lens
Volume49
Issue number12
DOIs
StatePublished - 1 Dec 2023
Externally publishedYes

Keywords

  • Dry eye
  • Dry eye treatment
  • Meibomian gland disease
  • Ocular surface
  • Ocular surface disease
  • Tear film

Fingerprint

Dive into the research topics of 'Update on Dry Eye Disease Treatment: Evidence From Randomized Controlled Trials'. Together they form a unique fingerprint.

Cite this